IN2015DN02907A - - Google Patents

Info

Publication number
IN2015DN02907A
IN2015DN02907A IN2907DEN2015A IN2015DN02907A IN 2015DN02907 A IN2015DN02907 A IN 2015DN02907A IN 2907DEN2015 A IN2907DEN2015 A IN 2907DEN2015A IN 2015DN02907 A IN2015DN02907 A IN 2015DN02907A
Authority
IN
India
Prior art keywords
disintegrating
particle composition
tablet
acid
present
Prior art date
Application number
Other languages
English (en)
Inventor
Hiramura Takahiro
Ikura Kiyoshi
Ishikawa Sae
Okabayashi Tomohito
Hashikawa Naohiro
Morita Tetsuro
Ikeda Kimiko
Original Assignee
Daicel Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Daicel Corp filed Critical Daicel Corp
Publication of IN2015DN02907A publication Critical patent/IN2015DN02907A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2059—Starch, including chemically or physically modified derivatives; Amylose; Amylopectin; Dextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Zoology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Inorganic Chemistry (AREA)
IN2907DEN2015 2012-09-20 2013-09-13 IN2015DN02907A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2012206897 2012-09-20
PCT/JP2013/074823 WO2014046035A1 (ja) 2012-09-20 2013-09-13 酸型カルボキシメチルセルロース及び結晶セルロースを含む崩壊性粒子組成物及び該組成物を含む口腔内崩壊錠剤

Publications (1)

Publication Number Publication Date
IN2015DN02907A true IN2015DN02907A (ja) 2015-09-11

Family

ID=50341348

Family Applications (1)

Application Number Title Priority Date Filing Date
IN2907DEN2015 IN2015DN02907A (ja) 2012-09-20 2013-09-13

Country Status (8)

Country Link
US (1) US10292934B2 (ja)
EP (1) EP2898899B1 (ja)
JP (1) JP6230539B2 (ja)
KR (1) KR102114487B1 (ja)
CN (1) CN104010663B (ja)
IN (1) IN2015DN02907A (ja)
TW (1) TWI639446B (ja)
WO (1) WO2014046035A1 (ja)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI673069B (zh) * 2013-07-06 2019-10-01 日商大賽璐股份有限公司 超高速崩解錠劑及其製造方法
JP6302921B2 (ja) * 2013-09-27 2018-03-28 株式会社ダイセル 崩壊性粒子組成物を含む口腔内崩壊錠剤
CN105555316B (zh) 2013-09-27 2020-07-07 株式会社大赛璐 通过二阶段的湿式制粒工序制备的崩解性颗粒组合物及含有该组合物的口腔内崩解片剂
JP2017226600A (ja) * 2014-10-16 2017-12-28 株式会社ダイセル 超速崩壊錠剤
CA2968210A1 (en) 2014-11-24 2016-06-02 Daicel Corporation A disintegrative particulate composition comprising milled lactose or granulated lactose
US10426732B2 (en) 2014-12-25 2019-10-01 Daicel Corporation Rapidly disintegrating tablet, and method for producing same
TWI695722B (zh) * 2015-06-29 2020-06-11 日商大賽璐股份有限公司 固態製劑之外層用組成物及含有該外層用組成物之易服用性固態製劑
ES2607715B1 (es) 2015-10-01 2018-01-17 Solutex Na, Lcc Proceso para la preparación y estabilización de emulsiones con omega-3 mediante redes cristalinas isométricas de derivados de celulosa
CN108463216B (zh) * 2016-01-18 2021-12-31 株式会社大赛璐 口腔内保持型崩解性固体制剂、其制造方法和用于该制造方法的粉体组合物
JP2019156723A (ja) * 2018-03-07 2019-09-19 大原薬品工業株式会社 圧縮成形性に優れた賦形剤を用いる、浸透膨潤型口腔内崩壊錠
JP7036856B2 (ja) * 2019-03-28 2022-03-15 日本ケミファ株式会社 口腔内崩壊錠
CA3158393A1 (en) * 2019-11-07 2021-05-14 Asahi Kasei Kabushiki Kaisha Cellulose composition, tablet, and orally disintegrating tablet
EP4061328B1 (en) 2019-11-22 2024-01-03 Biohorm, S.L. Zonisamide orodispersible tablets

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2851453A (en) 1954-08-09 1958-09-09 Smith Kline French Lab Cellulose derivative product, compositions comprising the same and their preparation
JPH10182436A (ja) 1996-10-31 1998-07-07 Takeda Chem Ind Ltd 固形医薬製剤
JP2000273039A (ja) * 1999-01-20 2000-10-03 Taisho Pharmaceut Co Ltd 口腔内崩壊性組成物
JP2000290172A (ja) * 1999-04-09 2000-10-17 Earth Chem Corp Ltd 発泡タブレット
CA2424770A1 (en) * 2000-10-06 2003-04-03 Takeda Chemical Industries, Ltd. Solid pharmaceutical preparation
JP4284017B2 (ja) * 2000-10-06 2009-06-24 武田薬品工業株式会社 固形製剤
JP4551627B2 (ja) 2003-02-28 2010-09-29 東和薬品株式会社 口腔内崩壊錠剤の製造方法
KR101465803B1 (ko) 2005-08-10 2014-11-26 시오노기세이야쿠가부시키가이샤 구강내 붕괴 정제
JP5123517B2 (ja) 2005-11-14 2013-01-23 帝人ファーマ株式会社 アンブロキソール口腔内速崩性錠剤
JP5766899B2 (ja) * 2007-04-11 2015-08-19 ニプロ株式会社 口腔内崩壊剤及びその製造方法
JP2008285434A (ja) 2007-05-16 2008-11-27 Taisho Pharm Ind Ltd 口腔内速崩壊錠
JP5627455B2 (ja) 2007-06-06 2014-11-19 ビーエーエスエフ ソシエタス・ヨーロピアＢａｓｆ Ｓｅ 速崩性錠剤製造のための医薬製剤
CN102006861B (zh) * 2008-02-13 2012-11-21 大日本住友制药株式会社 口腔崩解片
CN102548542B (zh) * 2009-08-11 2013-11-20 大日本住友制药株式会社 含有两种以上粒子的口腔速崩片
US9446055B2 (en) 2009-08-11 2016-09-20 Fuji Chemical Industry Co., Ltd. Disintegrating particle composition and orally rapidly disintegrating tablet
US20110150989A1 (en) 2009-12-22 2011-06-23 Mallinkckrodt Inc. Methods of Producing Stabilized Solid Dosage Pharmaceutical Compositions Containing Morphinans
JP6073543B2 (ja) 2010-07-08 2017-02-01 沢井製薬株式会社 ロラタジン含有口腔内崩壊錠の製造方法
JP6245677B2 (ja) * 2012-01-20 2017-12-13 ニプロ株式会社 口腔内崩壊錠
WO2013146917A1 (ja) 2012-03-29 2013-10-03 株式会社ダイセル 酸型カルボキシメチルセルロースを含む崩壊性粒子組成物の製造方法、並びに、該組成物及び該組成物を含む口腔内崩壊錠剤

Also Published As

Publication number Publication date
EP2898899A1 (en) 2015-07-29
JPWO2014046035A1 (ja) 2016-08-18
EP2898899B1 (en) 2019-09-11
US20150238424A1 (en) 2015-08-27
KR102114487B1 (ko) 2020-05-22
US10292934B2 (en) 2019-05-21
TWI639446B (zh) 2018-11-01
EP2898899A4 (en) 2016-03-16
CN104010663B (zh) 2021-02-19
KR20150056636A (ko) 2015-05-26
TW201417843A (zh) 2014-05-16
WO2014046035A1 (ja) 2014-03-27
CN104010663A (zh) 2014-08-27
JP6230539B2 (ja) 2017-11-15

Similar Documents

Publication Publication Date Title
IN2015DN02907A (ja)
EA033343B1 (ru) Соединения, ингибирующие rip2-киназу, фармацевтическая композиция на их основе и их применение для лечения заболеваний, опосредуемых rip2-киназой
PH12015501385A1 (en) Autotaxin inhibitors
IN2015DN01156A (ja)
MY189427A (en) Pyrazolyl quinoxaline kinase inhibitors
EP4036240A3 (en) Transduction buffer
GEP20156347B (en) Benzodioxane inhibitors of leukotriene production
UA109661C2 (uk) Фармацевтична композиція співкристалів трамадолу і коксибів
TN2012000534A1 (en) Pyrazole compounds as sigma receptor inhibitors
SG171542A1 (en) Pharmaceutical composition comprising a strontium salt, vitamin d and a cyclodextrin
MX2016000794A (es) Composiciones farmaceuticas de pancreatina de potencia alta.
WO2011025286A3 (ko) 리포테이코익산 유래 당지질 및 이를 포함하는 조성물
MY195343A (en) A Novel Phtalazinone Derivatives and Manufacturing Process Thereof
WO2011048563A3 (en) Orally disintegrating tablets of betahistine
IN2013MU03583A (ja)
WO2011104652A3 (en) Veterinary compositions
TN2012000507A1 (en) Enteric tablet
MX2016000480A (es) Composiciones farmaceuticas de pancreatina de alta potencia.
MX2012001691A (es) Composiciones de linaclotida que se desintegran oralmente.
CA2890042C (en) 1-[1-(benzoyl)-pyrrolidine-2-carbonyl]-pyrrolidine-2-carbonitrile derivatives
MX366829B (es) Composiciones y formas de dosificacion de itraconazol y metodos de uso de las mismas.
IN2014DN03010A (ja)
IN2015DN02296A (ja)
MX2010008707A (es) Composiciones farmaceuticas de entacapona comicronizada con alcoholes de azucar.
WO2010086617A3 (en) Phosphoantigens for the treatment of burkholderia infections